Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs

[Image: see text] Although tyrosine kinase inhibitors (TKIs) have revolutionized cancer therapy in the past two decades, severe drawbacks such as strong adverse effects and drug resistance limit their clinical application. Prodrugs represent a valuable approach to overcoming these disadvantages by a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Inorg Chem
Autores principales: Mathuber, Marlene, Schueffl, Hemma, Dömötör, Orsolya, Karnthaler, Claudia, Enyedy, Éva A., Heffeter, Petra, Keppler, Bernhard K., Kowol, Christian R.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Chemical Society 2020
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724630/
https://ncbi.nlm.nih.gov/pubmed/33222438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.inorgchem.0c03083
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares